Light-Induced Toxic Effects of Tamoxifen: A Chemotherapeutic and Chemopreventive Agent
- PMID: 20046228
- PMCID: PMC2637528
- DOI: 10.1016/j.jphotochem.2008.09.013
Light-Induced Toxic Effects of Tamoxifen: A Chemotherapeutic and Chemopreventive Agent
Abstract
Tamoxifen is a powerful drug used to treat breast cancer patients, and more than 500,000 women in the U. S. are being treated with this drug. In our study, tamoxifen is found to be photomutagenic in Salmonella typhimurium TA102 at concentrations as low as 0.08 muM and reaches maximum photomutagenicity at 0.4 muM under a light dose equivalent to 20 min sunlight. These concentrations are comparable to the plasma tamoxifen concentration of 0.4 to 3 muM for patients undergoing tamoxifen therapy. The toxicity seems to be the result of DNA damage and/or lipid peroxidation caused by light irradiation of tamoxifen. The DNA damage caused by irradiation of PhiX174 DNA in the presence of tamoxifen appears to be formation of DNA-tamoxifen covalent adducts, not single strand/double strand cleavages, and there is no oxygen involvement. This is confirmed by EPR experiments that carbon-centerd radicals are formed by light irradiation of tamoxifen and there is no singlet oxygen formation. Although superoxide radical is formed, it is not involved in DNA damage.
Figures








Similar articles
-
UVA-Induced DNA single-strand cleavage by 1-hydroxypyrene and formation of covalent adducts between DNA and 1-hydroxypyrene.Chem Res Toxicol. 2000 Jul;13(7):585-93. doi: 10.1021/tx990199x. Chem Res Toxicol. 2000. PMID: 10898590
-
Bacterial photomutagenicity testing: distinction between direct, enzyme-mediated and light-induced events.Mutat Res. 1996 Sep 26;361(1):41-8. doi: 10.1016/s0165-1161(96)90228-9. Mutat Res. 1996. PMID: 8816942
-
Photodecomposition of retinyl palmitate in ethanol by UVA light-formation of photodecomposition products, reactive oxygen species, and lipid peroxides.Chem Res Toxicol. 2005 Feb;18(2):129-38. doi: 10.1021/tx049807l. Chem Res Toxicol. 2005. PMID: 15720116
-
The tamoxifen dilemma.Carcinogenesis. 1999 Jul;20(7):1153-60. doi: 10.1093/carcin/20.7.1153. Carcinogenesis. 1999. PMID: 10383884 Review.
-
Is tamoxifen a genotoxic carcinogen in women?Mutagenesis. 2009 Sep;24(5):391-404. doi: 10.1093/mutage/gep022. Epub 2009 Jun 7. Mutagenesis. 2009. PMID: 19505894 Review.
Cited by
-
Toxic effects of gold nanoparticles on Salmonella typhimurium bacteria.Toxicol Ind Health. 2011 Jul;27(6):547-54. doi: 10.1177/0748233710393395. Epub 2011 Mar 17. Toxicol Ind Health. 2011. PMID: 21415096 Free PMC article.
-
Tamoxifen Citrate Containing Topical Nanoemulgel Prepared by Ultrasonication Technique: Formulation Design and In Vitro Evaluation.Gels. 2022 Jul 21;8(7):456. doi: 10.3390/gels8070456. Gels. 2022. PMID: 35877541 Free PMC article.
-
Breast cancer medications and vision: effects of treatments for early-stage disease.Curr Eye Res. 2011 Oct;36(10):867-85. doi: 10.3109/02713683.2011.594202. Epub 2011 Aug 5. Curr Eye Res. 2011. PMID: 21819259 Free PMC article. Review.
-
Electron spin resonance spectroscopy for the study of nanomaterial-mediated generation of reactive oxygen species.J Food Drug Anal. 2014 Mar;22(1):49-63. doi: 10.1016/j.jfda.2014.01.004. Epub 2014 Feb 1. J Food Drug Anal. 2014. PMID: 24673903 Free PMC article. Review.
-
Fate mapping melanoma persister cells through regression and into recurrent disease in adult zebrafish.Dis Model Mech. 2022 Sep 1;15(9):dmm049566. doi: 10.1242/dmm.049566. Epub 2022 Sep 16. Dis Model Mech. 2022. PMID: 35929478 Free PMC article.
References
-
- Harwood KV. Advances in endocrine therapy for breast cancer: considering efficacy, safety, and quality of life. Clin J Oncology. 2004;8:629–637. - PubMed
-
- Shibutani S, Ravindernath A, Suzuki M, Terashima I, Sugarman SM, Grollman AP, Paearl ML. Identification of tamoxifen-DNA adducts in the endometrium of women treated with tamoxifen. Carcinogenesis. 2000;21:1461–1467. - PubMed
-
- Shibutani S, Reardon JT, Suzuki M, Sancar A. Excision of tamoxifen-DNA adducts by the human nucleotide excision repair system. Cancer Res. 2000;60:2607–2610. - PubMed
-
- Glatt H, Davis W, Meinl W, Hermersdörfer H, Venitt S, Phillips DH. Rat, but not human, sulfotransferase activates a tamoxifen metabolite to prodice DNA adducts and gene mutations in bacteria and mammalian cells in culture. Carcinogenesis. 1998;19:1709–1713. - PubMed
-
- Divi RL, Osborne MR, Hewer A, Phillips DH, Poirier MC. Tamoxifen-DNA adduct formation in rat liver determined by immunoassay and 32P-Postlabeling. Cancer Res. 1999;59:4829–4833. - PubMed
Grants and funding
LinkOut - more resources
Full Text Sources